Experienced Pharmaceutical Sales Director
Chris Manfuso
Based in Mt. Pleasant, South Carolina, Christopher Manfuso is the national director of sales for Nubratori RX and Enovachem Pharmaceuticals, sister companies that were founded by Robert P. Nickell. Chris Manfuso has more than two decades of experience in pharmaceuticals and healthcare with additional expertise in ancillary program management, durable equipment sales, and business-to-business sales.
At Nubratori RX, Manfuso leverages this experience and expertise to sell a line of pharmaceutical products, including Frotek (topical ketoprofen) and Neuraptine (topical gabapentin), on behalf of the FDA-approved Outsourcing Facility. The company, which launched following the enactment of the Drug Quality and Securities Act of 2013, had its first production run in 2017 after four years of research and development. It has since produced more than 100,000 sterile and non-sterile medications and is licensed to ship to 37 states.
experience and expertise
Pharmaceuticals & Healthcare
At Enovachem, Chris Manfuso oversees national sales efforts for the company’s prepackaged hormone kits and other products. The FDA-registered, cGMP pharmaceutical company provides a range of EC-RX™ Kits (DHEA, Estradiol, Progesterone, and Testosterone) to licensed physicians and pharmacists. The company markets its products to alternative care practice physicians, OB/GYNs, medical aesthetic practice managers, urologists, and male/female hormone replacement therapy clinics.
As the national director of sales for both of these companies, Manfuso works to improve revenue generation and increase distribution. He achieves this by utilizing digital strategic marketing partnerships and hiring and developing effective sales team personnel. He has previous sales experience with Merck Pharmaceuticals in San Diego, California, and is also the owner of Physician Ancillary Management.
An alumnus of James Madison University in Harrisburg, Virginia, Chris Manfuso graduated cum laude with a bachelor’s degree in finance.